ISRCTN82857232已完成未知
A randomised controlled trial to test the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider
Medical Research Council (UK)0 个研究点目标入组 1,267 人开始时间: 2012年10月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,267
研究概览
简要总结
2014 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/24943673 protocol 2017 Results article in http://www.ncbi.nlm.nih.gov/pubmed/28478041 results 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34743721/ secondary analysis (added 10/11/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35796997/ Relationship between BMI and quality of life (added 08/07/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. BMI =28 kg/m2
- •2. Aged =18 years
- •3. Willing and able to comply with the study procedures
- •For simplicity, we will not vary the BMI criteria by ethnic group.
排除标准
- •1. Planned or current pregnancy in the next two years
- •2. Previous or planned bariatric surgery
- •GPs will be allowed to define any additional inclusion/exclusion criteria to meet local practice and will be asked to provide details on these for the reporting of the study. No further criteria will be imposed, thus capturing the population that would typically be referred to these treatments. Participants receiving other weight loss treatments, e.g. Orlistat, will not be excluded as such participants would still be eligible for commercial referrals in standard practice, but this will be adjusted for in the analyses. Participants will be randomised to intervention arms, and thus those receiving additional treatment should be evenly spread across the interventions and these treatments will be accounted for in the cost-effectiveness analyses.
研究者
相似试验
已完成
不适用
Optimized TacrolimuS and MMF for HLA Antibodies after Renal TransplantatioTopic: Renal and UrogenitalSubtopic: Renal and Urogenital (all Subtopics)Disease: RenalInjury, Occupational Diseases, PoisoningKidney transplant failure and rejectionISRCTN46157828King's College London (UK)2,037
已完成
不适用
Brief intervention for weight lossObesity in primary careNutritional, Metabolic, EndocrineObesityISRCTN26563137niversity of Oxford (UK)1,882
已完成
2 期
The clinical effectiveness, safety and cost effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitisOphthalmologyEye DiseasesIridocyclitisISRCTN10065623niversity Hospitals Bristol NHS Foundation Trust (UK)90
已完成
不适用
Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD): a Randomised Controlled TrialAdult Attention Deficit Hyperactivity Disorder (ADHD)Mental and Behavioural DisordersOther disorders of adult personality and behaviourISRCTN03732556South London and Maudsley NHS Foundation Trust (UK)60
已完成
不适用
Barrier Enhancement for Eczema PreventioTopic: Children, Primary Care, DermatologySubtopic: All Diagnoses, Not Assigned, Skin (all Subtopics)Disease: Dermatology, All Diseases, All DiseasesSkin and Connective Tissue DiseasesISRCTN21528841niversity of Nottingham (UK)1,394